CEFPIRAMIDE SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cefpiramide Sodium patents expire, and what generic alternatives are available?
Cefpiramide Sodium is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.
Summary for CEFPIRAMIDE SODIUM
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 32 |
Patent Applications: | 346 |
DailyMed Link: | CEFPIRAMIDE SODIUM at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CEFPIRAMIDE SODIUM
US Patents and Regulatory Information for CEFPIRAMIDE SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | CEFPIRAMIDE SODIUM | cefpiramide sodium | INJECTABLE;INJECTION | 050633-002 | Jan 31, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CEFPIRAMIDE SODIUM | cefpiramide sodium | INJECTABLE;INJECTION | 050633-003 | Jan 31, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | CEFPIRAMIDE SODIUM | cefpiramide sodium | INJECTABLE;INJECTION | 050633-005 | Jan 31, 1989 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |